Axogen (AXGN) Posts Q4 Loss of 24c/Share; FY13 Revs Rose 42%
Axogen (NASDAQ: AXGN) reported Q4 EPS of ($0.24), $0.03 worse than the analyst estimate of ($0.21). Revenue for the quarter ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
